The DOI matches its Crossref record; 10 of the 11 references it cites were found in a registry or an index, and 1 are not checked yet.
Increased odds of death for patients with interstitial lung disease and covid-19: a case-control study
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, COVID-19 survivors are susceptible to developing pulmonary fibrosis-like symptoms.87,88”
From The costs and benefits of senotherapeutics for human health (2022) · cites this paper as [87]
In the citing paper
“Patients with idiopathic pulmonary fibrosis are extremely susceptible to developing COVID-19 after infection with SARS-CoV-2.87,88”
From The costs and benefits of senotherapeutics for human health (2022) · cites this paper as [87]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dexamethasone in Hospitalized Patients with Covid-19
The RECOVERY Collaborative Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021436 · Cited by 11,477
Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report
Horby, P., Lim, W. S., Emberson, J., Mafham, M., Bell, J., Linsell, L., Staplin, N., Brightling, C., Ustianowski, A., Elmahi, E., et al. (2020) · doi:10.1101/2020.06.22.20137273 · Cited by 11,475
Yang, J., Zheng, Y., Gou, X., Pu, K., Chen, Z., Guo, Q., Ji, R., Wang, H., Wang, Y., & Zhou, Y. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.017 · Cited by 4,206
Comorbidity and its impact on 1590 patients with covid-19 in China: a nationwide analysis
Guan, W.-J., Liang, W.-H., Zhao, Y., Liang, H.-R., Chen, Z.-S., Li, Y.-M., Liu, X.-Q., Chen, R.-C., Tang, C.-L., Wang, T., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.00547-2020 · Cited by 3,680
Garg, S., Kim, L., Whitaker, M., O’Halloran, A., Cummings, C., Holstein, R., Prill, M., Chai, S. J., Kirley, P. D., Alden, N. B., et al. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6915e3 · Cited by 2,335
Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan
Li, X., Xu, S., Yu, M., Wang, K., Tao, Y., Zhou, Y., Shi, J. C., Zhou, M., Wu, B., Yang, Z., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.04.006 · Cited by 2,273
Fu, L., Wang, B., Yuan, T., Chen, X., Ao, Y., Fitzpatrick, T., Li, P., Zhou, Y., Lin, Y., Duan, Q., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.03.041 · Cited by 1,141
Alqahtani, J. S., Oyelade, T., Aldhahir, A. M., Alghamdi, S., Almehmadi, M., Alqahtani, A., Quaderi, S. A., Mandal, S., & Hurst, J. R. (2020) · PLoS ONE · doi:10.1371/journal.pone.0233147 · Cited by 897
Li, H., Chen, C., Hu, F., Wang, J., Zhao, Q., Gale, R. P., & Liang, Y. (2020) · Leukemia · doi:10.1038/s41375-020-0848-3 · Cited by 262
The Role of Infection in Interstitial Lung Diseases
Azadeh, N., Limper, A. H., Carmona, E. M., & Ryu, J. H. (2017) · Chest · doi:10.1016/j.chest.2017.03.033 · Cited by 115
Southern, B. D. (2020) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.87a.ccc026 · Cited by 31
Cited by
Sorted by citations
Risk factors for severe and critically ill COVID‐19 patients: A review
Gao, Y., Ding, M., Dong, X., Zhang, J., Azkur, A. K., Azkur, D., Gan, H. K., Sun, Y., Fu, W., Li, W., et al. (2020) · Allergy · doi:10.1111/all.14657 · Cited by 1,453
Tuning immunity through tissue mechanotransduction
Du, H., Bartleson, J. M., Butenko, S., Alonso, V., Liu, W. F., Winer, D. A., & Butte, M. J. (2022) · Nature reviews. Immunology · doi:10.1038/s41577-022-00761-w · Cited by 451
Idiopathic pulmonary fibrosis: state of the art for 2023
Podolanczuk, A. J., Thomson, C. C., Remy-Jardin, M., Richeldi, L., Martinez, F. J., Kolb, M., & Raghu, G. (2023) · European Respiratory Journal · doi:10.1183/13993003.00957-2022 · Cited by 359
The costs and benefits of senotherapeutics for human health
Raffaele, M., & Vinciguerra, M. (2022) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(21)00300-7 · Cited by 140
Interstitial lung disease increases susceptibility to and severity of COVID-19
Lee, H. J., Choi, H., Yang, B., Lee, S.-K., Park, T. S., Park, D. W., Moon, J., Kim, T., Sohn, J. W., Yoon, H. J., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.04125-2020 · Cited by 115
Metadata
- Authors
- Esposito, A. J., Menon, A. A., Ghosh, A. J., Putman, R. K., Fredenburgh, L. E., El-Chemaly, S. Y., Goldberg, H. J., Baron, R. M., Hunninghake, G. M., & Doyle, T. J.
- Affiliations
- Brigham and Women's Hospital (US)
- Brigham and Women’s Hospital, Boston, Massachusetts
- Corresponding author
- Doyle, Tracy J.
- ORCID
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-12-01
- Volume
- 202
- Issue
- 12
- Pages
- 1710-1713
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- PMC
- PMC7737588
- OpenAlex
- W3083942257
- Cited by
- 142
- References
- 9
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 15 · 2023: 37 · 2022: 44 · 2021: 28 · 2020: 4
- FWCI
- 3.71
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (L30HL149048, R01HL111024, F32HL151132, K08HL140087, R01HL130974, R01HL135142)
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Keywords
- interstitial lung disease, COVID-19 pandemic, mortality, SARS-CoV-2, comorbidities, risk factors
- MeSH terms
- COVID-19, SARS-CoV-2, Aged, Aged, 80 and over, Cause of Death, Female, Humans, Male, Middle Aged, Retrospective Studies, United States, Comorbidity, Survival Rate, Case-Control Studies, Lung Diseases, Interstitial, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
